Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerationsJun Gong, Ravi Salgia|Journal for ImmunoTherapy of Cancer|2018Cited by 1.3k
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combinationJun Gong, Richard Tuli|Journal for ImmunoTherapy of Cancer|2018Cited by 190
Diabetes, pancreatic cancer, and metformin therapyJun Gong, Stephen J. Pandol|Frontiers in Physiology|2014Cited by 66
Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1Jun Gong, Keith T. Flaherty, Zihan Wei et al.|JCO Precision Oncology|2024Cited by 16